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Peptidylprolyl eis-trans isomerases (PPIases) are ubiquitous 
proteins that catalyze the eis-trans isomerization of prolines. A 
number of proteins, such as Drosophila rhodopsin and the 
human immunodeficiency viral protein HIV-1 Gag, have been 
identified as endogenous substrates for PPIases. However, very 
little is known about the interaction of PPIases with small, dis- 
ulfide-rieh peptides. Marine cone snails synthesize a wide array 
of cysteine-rich peptides, called conotoxins, many of which con­
tain one or more prolines or hydroxyprolines. To identify 
whether PPIase-associated cis-trans isomerization of these res­
idues affects the oxidative folding of conotoxins, we identified, 
sequenced, and expressed three functionally active isoforms of 
PPIase from the venom gland of Conus novaehollandiae, and we 
characterized their ability to facilitate oxidative folding of cono­
toxins in vitro. Three conotoxins, namely /n-GIIIA, ju,-SIIIA, and 
to-MVIIC, derived from two distinct toxin gene families were 
assayed. Conus PPIase significantly increased the rate of appear­
ance of the native form of /n-GIIIA, a peptide containing three 
hydroxyprolines. In contrast, the presence of PPIase had no effect 
on the folding of ju,-SIIIA and to-M VIIC, peptides containing no or 
one proline residue, respectively. We further showed that an endo­
plasmic reticulum-resident PPIase isoform facilitated folding of 
/U.-GIIIA more efficiently than two cytosolic isoforms. This is the 
first study to demonstrate PPIase-assisted folding of conotoxins, 
small disulfide-rich peptides with unique structural properties.
Predatory marine cone snails (genus Conus) synthesize a great 
diversity (>50,000) of neurotoxic peptides commonly referred to 
as conotoxins. Conotoxins selectively target specific subtypes of 
receptors or ion channels throughout the nervous system, a char­
acteristic that has lead to wide use of conotoxins in ion channel 
research and as therapeutic agents (for review see Refs.l and 2). It 
is now well understood that the vast diversity of conotoxins is 
driven by two major events: gene duplication followed by hyper­
mutation of the mature toxin region (3) and the generation of
posttranslational modifications (for review see Ref. 4). Posttrans- 
lational modifications in Conus generally aid in stabilizing the pep­
tide structure (5,6) as well as varying the structure and shape of the 
peptide to optimize target binding (7-9).
The most common posttranslational modification is the for­
mation of disulfide bonds, a characteristic shared with neuro­
toxins from other venomous animals, antimicrobial peptides 
such as the defensins, and peptide proteinase inhibitors (Table 
1). Conotoxins can be grouped into several superfamilies on the 
basis of their N-terminal signal sequence and their conserved 
disulfide framework. Interestingly, despite thousands of differ­
ent toxin sequences biosynthesized there are only 12-18 struc­
tural scaffolds found in vivo, an obscurity recently referred to as 
the “conotoxin folding puzzle” (10). Even within the same disul­
fide scaffold, various conotoxins display an array of folding 
properties, suggesting that neither the Cys pattern nor the pri­
mary amino acid sequence is a key folding determinant in vitro 
(10). Discrepancies between in vivo and in vitro folding of cono­
toxins are emerging (10), with toxins that are difficult to syn­
thesize chemically often being highly abundant in the snail 
venom gland (11, 12). These findings strongly suggest that the 
three-dimensional structure that conotoxins adopt in vivo is deter­
mined by specific interactions with folding enzymes and molecu­
lar chaperones. One apparent folding catalyst in the biosynthesis 
of cysteine-rich peptides is protein-disulfide isomerase (PDI).2 
The oxidation and isomerization of disulfide bonds in the ER of 
Conus are now known to be catalyzed by PDI (13), one of the most 
abundant soluble proteins in the venom gland of Conus (14, 15). 
Given the structural complexity of conotoxins, mechanisms other 
than PDI-mediated folding are likely to occur.
A great number of conotoxins comprise one or more proline 
(Pro) residues, some of which are important for toxin-target 
interactions (16, 17). Hydroxylation of these Pro residues is a 
common modification in Conus and has recently been reported 
to affect the oxidative folding properties of several conotoxins 
including w-MVIIC, a toxin with very poor in vitro folding
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yields (18). Hydroxylation of Pro leads to a 2-fold increase in 
folding yields, whereas the neurotoxic activity of the toxin is 
maintained. For the /n-conotoxin GIIIA, the modification 
enhances bioactivity but does not affect folding. In contrast, Pro 
hydroxylation impairs activity but improves folding yields in 
the two a-conotoxins Iml and Gl, which naturally contain a 
conserved Pro residue (18). These findings emphasize the 
importance of Pro hydroxylation in the structure and bioactiv­
ity of conotoxins. Hydroxylation of Pro has been reported for a 
number of proteins including collagen, a well studied substrate 
of the enzyme peptidylprolyl cis-trans isomerase (PPIase) 
(19-21).
PPIases are ubiquitous enzymes found in vertebrates, inver­
tebrates, plants, and bacteria and are present in almost all cel­
lular compartments (for review see Ref. 22). Today the terms 
PPIases, cyclophilins (Cyp), and immunophilins are often used 
synonymously. Genome analysis of the yeast Saccharomyces 
cerevisiae identified at least eight different isoforms (23), none 
of which are essential for its survival (24). The human genome 
comprises at least 16 genes encoding for Cyp-like proteins, 
eight of which have been identified in vivo (for review see Ref. 
22). Many functions have been described for these diverse pro­
teins including roles in cellular signaling (25) and the regulation 
of gene transcription (26, 27) and as chaperones and folding 
catalysts (28-30). Mammalian CypA is located in the cytosol 
where it is known to bind the immunosuppressive drug cyclo- 
sporine (31). Formation of the CypA-cyclosporine complex 
prevents T-cell proliferation via inhibition of the protein phos­
phatase calcineurin (32,33). The two PPIase isoforms CypB and 
FKBP-13 reside in the ER (34,35) and are overexpressed during 
heat shock, suggesting a major role in the folding and/or assem­
bly of proteins (36, 37). Peptidylprolyl bonds can adopt two 
distinct conformations, cis or trans. PPIases catalyze the cis- 
trans isomerization of these bonds, an otherwise slow process 
that can impede protein folding. A number of proteins have 
been identified as in vivo (30, 38) and in vitro (19, 39) folding 
substrates for PPIases; however, little is known about their role 
in the folding of small cysteine-rich peptides. In the only study 
reported to date, the effects of the human cytosolic PPIase 
FKBP-12 on the oxidative folding of the scorpion toxin mauro- 
toxin were evaluated (for sequence see Table 1) (40). The pres­
ence of PPIase accelerated the disappearance of intermediate 
folding species but does not change the overall folding kinetics 
of maurotoxin in vitro (40).
To address the paucity of information on conotoxin biosyn­
thesis, the present study aimed to identify enzymes having the 
potential to assist conotoxin folding in vivo. We hypothesized 
that given the frequency of peptidylprolyl bonds in conotoxins 
and their importance for receptor binding, PPIase-mediated 
cis-trans isomerization of these bonds facilitates oxidative fold­
ing during toxin biosynthesis in the ER of Conus. To test this 
hypothesis we first identified and sequenced several PPIase iso­
forms in the venom gland of the Australian cone snail, Conus 
novaehollandiae, and recombinantly expressed functionally 
active enzymes. We demonstrate that PPIase-mediated isomer­
ization of peptidylprolyl bonds significantly affects the rate of 
formation of the native disulfide bonds for the /n-conotoxin 
GIIIA, a peptide with three hydroxyprolines (Hyp) and three
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disulfide bonds. We further show that an ER-resident PPIase is 
more active in accelerating the folding of /n-GIIIA when com­
pared with two cytosolic isoforms. This study furthers our 
knowledge on how cone snails efficiently synthesize such a 
great diversity of highly structured peptides and may shed light 
on the fundamental principals of oxidative folding of small cys­
teine-rich peptides.
EXPERIMENTAL PROCEDURES
Specimen Collection, Tissue Preparation, and Histology— 
Live specimens of C. novaehollandiae (Adams, 1854) were col­
lected from Broome, Western Australia. For protein and RNA 
extractions, venom glands, venom bulbs, and muscle tissues 
were dissected, immediately snap-frozen in liquid nitrogen, and 
stored at —80 °C until further processing. For histological prep­
arations, adult snails were transferred to seawater containing 
2% MgCl2 for 4 h. The shells were cracked, the viscera were 
removed, and overnight fixation was performed in 4% 
paraformaldehyde/phosphate-buffered saline. Fixed specimens 
were processed, sectioned (7 /nm), and stained with Mallory’s 
trichrome stain (41) following routine histological procedures.
Protein Extraction and Two-dimensional Gel Electrophoresis—  
Frozen venom ducts were pooled (a total of two samples pooled 
from three snails each), ground under liquid nitrogen, resus­
pended in 1 ml of cell lysis buffer (10 mM Tris-HCl, 100 mM 
NaCl, 1 mM EDTA, 1 mM NaF, 20 mM Na4P20 7, 1% Triton-X, 
10% glycerol, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, 
1X Complete protease inhibitor mixture (Roche Applied Sci­
ence), pH 7.6), and incubated for 30 min on ice. Cell lysates 
were centrifuged, and proteins were precipitated from the 
supernatants and reconstituted in rehydration buffer (8 m urea, 
2% CHAPS, 0.002% bromphenol blue, 20 mM dithiothreitol, 
0.5% immobilized pH gradient buffer, pH 3-11 (GE Health­
care)) at a final concentration of 1 mg/ml in preparation for 
isoelectric focusing (IEF). Protein precipitation (2-D Clean-Up 
Kit, GE Healthcare) and quantitation (BCA assay kit, Thermo 
Fisher Scientific) were performed according to the manufactur­
er’s instructions. Two hundred /ng of protein was applied onto a 
nonlinear, pH 3-11, immobilized pH gradient strip (Immobi- 
line, GE Healthcare) and rehydrated overnight. IEF was per­
formed on the Ettan IPGphor II IEF system (GE Healthcare). 
Running conditions were 500 V for 1 h at 0.5 kVh, 1000 V for 1 h 
at 0.8 kVh, 6000 V for 2 h at 7.0 kVh, and 6000 V for 40 min at 
0.7-3.7 kVh. Following IEF, strips were reduced in equilibra­
tion buffer (75 mM Tris-HCl, 6 m urea, 30% glycerol, 2% SDS, 
0.002% bromphenol blue) containing 65 mM dithiothreitol for 
15 min followed by alkylation for 15 min in the presence of 80 
mM iodoacetamide. Second dimension gel electrophoreses 
were performed on 8-16% Tris-HCl SDS-PAGE (Criterion, 
Bio-Rad) for 50 min at 200 V. Gels were stained with Coomassie 
Brilliant Blue G-250 (Bio-Rad). In-gel digestion and protein 
identification were performed as described previously (42). 
Briefly, two-dimensional gel electrophoresis spots were 
excised, washed in 50% acetonitrile/triethylammonium bicar­
bonate, and reduced with 20 mM dithiothreitol followed by 
alkylation in 100 mM iodoacetamide. In-gel digestion was per­
formed using sequencing grade trypsin (Sigma-Aldrich) at a 
final concentration of 10 /ng/ml in 25 mM triethylammonium
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TABLE 1
Diversity of proline/hydroxyproline-containing disulfide-rich peptides
*, C-terminal amidation; O, hydroxyproline; y, y-carboxylation of glutamate. Prolines/hydroxyprolines are highlighted gray, and cysteine residues are shown in bold.
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bicarbonate. Peptides extracted after overnight digestion were 
separated on a CIS column (Zorbax 80SB-C18, 74 /Am X 43 
mm, Agilent, Forest Hill, Victoria, Australia) and analyzed 
using a linear ion trap mass spectrometer (LC/MSD Trap XCT 
Plus, Agilent). MS/MS data were used to search the UniProt 
nonredundant protein data base using Mascot, version 2.2 
(Matrix Science, Boston) with the following settings: trypsin, 
one missed cleavage, carbamidomethyl as a fixed and oxidation
of methionine as a variable modification, 1.2 Da peptide toler­
ance, 0.8 Da MS/MS tolerance, with error-tolerant search 
included.
cDNA Isolation and Identification o f  Conus PPIase Tran­
scripts—  Three frozen venom ducts were pooled and ground 
under liquid nitrogen. Total RNA was extracted using TRIzol 
reagent (Invitrogen). Total RNA was treated with Turbo DNase 
(Ambion, Scoresby, Victoria, Australia). RNA concentrations
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were determined using a spectrophotometer, and RNA 
integrity was verified by agarose-gel electrophoresis. For 
rapid amplification of cDNA ends (RACE), 5' and 3' univer­
sal primer-adapted cDNA was prepared from 1000 ng of 
total RNA using the SMART1M RACE cDNA amplification 
kit (Clontech Laboratories, Mountain View, CA). RACE was 
performed using primary and nested PCR proprietary universal 
oligonucleotides and three gene-specific oligonucleotides 
(supplemental Table 1) designed on the basis of conserved gene 
regions and/or on peptide matches obtained using two-dimen­
sional gel electrophoresis coupled with LC/MS/MS (see above). 
Primary PCR reactions were performed in volumes of 50 fil 
containing 2.5 ju,l of 1:10 diluted cDNA, 0.5 ju,l of TITANIUM 
Taq DNA polymerase (Clontech), 1X Advantage 2 PCR buffer 
(Clontech), dNTPs at 200 /jlm, 5 /jl\ of 10X universal primer A 
mix (Clontech), and a gene-specific oligonucleotide (0.2 /jlm) 
(supplemental Table 1). If the PCR reaction did not produce a 
visible PCR amplicon, a nested PCR using 5 /jl\ of the primary 
PCR reaction was performed. To sequence the PPIase A-like 
isoforms, PCR was performed using redundant oligonucleo­
tides designed to amplify the open reading frame specifically 
(supplemental Table 1). All PCR amplicons were analyzed by 
gel electrophoresis, cloned into pGEM-T plasmid vectors (Pro- 
mega), and subsequently sequenced. Nucleotide sequencing 
was performed using the ABI Prism BigDye Terminator (ver­
sion 3.1) cycle sequencing kit (ABI) with the SP6 promoter oli­
gonucleotide (Promega). Samples were analyzed on an ABI 
3730x1 DNA analyzer (Applied Biosystems). All sequences ana­
lyzed in this study were deposited in GenBank1M (National 
Center for Biotechnology Information, U. S. National Library 
of Medicine, Bethesda, MD) with the accession numbers shown 
in supplemental Table 1. All nucleotide data were translated 
into the predicted amino acid sequences, and comparative 
alignment of the protein sequences were performed using 
MAFFT E-INS-i sequence alignment by means of local pairwise 
alignment information (43).The putative signal peptides were 
predicted using SignalP software (44).
Reverse Transcription (RT)-PCR—Total RNA was prepared 
as described above. cDNA was reverse-transcribed from 720 ng 
of DNase-treated total RNA extracted from venom glands, 
bulbs, and muscle (total of two samples/tissue, pooled from 
three snails each) using the Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche Applied Science). Primary RT-PCR reac­
tions were performed in volumes of 30 /jl\ containing 2 /jl\ of 
cDNA (60 ng), 0.3 ju,l of TITANIUM Taq DNA polymerase 
(Clontech), IX  Advantage 2 PCR buffer (Clontech), dNTPs at 
200 /jlm, and 0.2 /jlm forward and reverse oligonucleotides 
(supplemental Table 1). To rule out false amplification of 
genomic DNA, a negative control was performed using the 
reaction from which the enzyme reverse transcriptase was 
excluded. To ensure linearity of the reaction and rule out PCR 
inhibition, RT-PCR on all oligonucleotides and tissues was per­
formed with different concentrations of template cDNA (0.6,6, 
60, and 600 ng) for 25, 30, and 35 amplification cycles (data not 
shown). All PCR amplicons were analyzed by gel electrophore­
sis and subsequently sequenced as described above.
Cloning, Expression, and Purification o f PPIase Isofonns— 
Full-length PPIA (isomers I and II) and PPIB lacking the N-ter-
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minal signal sequence were cloned into the pET22b+ expres­
sion vector containing a C-terminal His6 tag (Novagen, Kilsyth, 
Victoria, Australia). Transcripts were PCR-amplified from 
venom gland cDNA prepared as described above (see 
supplemental Table 1 for oligonucleotide sequences used). PCR 
amplicons were ligated into pET22b+ using the BamHI (5') 
and Xhol (3') restriction sites (New England Biolabs, Arundel, 
Queensland, Australia), and sequences were verified as 
described above. Constructs were transformed into the Rosetta 
strain of Escherichia coli (Novagen). For expression of Conus 
PPIases, Luria broth medium (Sigma-Aldrich) containing 
ampicillin (100 fig/ml) and tetracycline (12.5 fig/ml) was inoc­
ulated with overnight cultures and incubated at 37 °C with 
shaking until the j4600 spectrophotometric reading was 0.6. 
After the addition of Isopropyl-|3-D-thiogalactopyranoside 
(final concentration 0.1 him) the bacterial culture was further 
incubated for 3 h at 25 °C with shaking. Bacteria were harvested 
and resuspended in native lysis buffer (50 him NaH2P0 4, 300 
mM NaCl, 10 mM imidazole (Sigma-Aldrich), pH 8.0) contain­
ing protease inhibitors (Complete protease inhibitor mixture, 
Roche Applied Science). Bacterial cells were lysed by incubat­
ing them with lysozyme (1 mg/ml, Sigma-Aldrich) on ice for 30 
min followed by probe tip sonication. Cellular debris and insol­
uble protein were pelleted by centrifugation, and the superna- 
tants were used for subsequent protein purifications.
Recombinant Conus PPIases were purified on a 1-ml immo­
bilized metal affinity column under native conditions (Bio­
Scale Mini Profmity IMAC cartridge, Bio-Rad). Protein purifi­
cation was performed using the Bio-Rad Profmia protein 
purification system. Briefly, protein lysates were loaded onto 
the column at 0.5 ml/min, and nonspecifically bound proteins 
were removed with native buffer (NB: 300 mM I<C1, 50 mM 
I<H2P0 4, pH 8.0) containing 5 mM imidazole at 2 ml/min for 6 
min followed by a second wash with NB containing 10 mM 
imidazole for 3 min. His-tagged proteins were eluted with 250 
mM imidazole in NB at 2 ml/min for 2 min. Further purification 
and buffer exchange into 0.1 m Tris-HCl, pH 8.0, containing 150 
mM NaCl was accomplished by size exclusion chromatography 
(Superdex 200, HiLoad 16/60, GE Healthcare). Protein concen­
trations were determined spectrophotometrically using the 
molar absorption coefficients of the proteins (45). The purified 
recombinant proteins were analyzed by SDS-PAGE and 
sequence-verified by in-gel digestion and analysis of proteo- 
typic tryptic peptides as described above.
Protease-coupled PPIase Assay—PPIase activity of recombi­
nant proteins was determined using the coupled chymotrypsin 
assay (46) with modifications. Briefly, PPI (final concentrations 
30 nM for PPI A (I) and (II) and 300 nM for PPI B) was added to 
0.1 m Tris-HCl, pH 8, in the absence and presence of a 10X 
excess of the inhibitor cyclosporine (final concentrations 90 nM 
for PPI A (I) and (II) and 900 nM for PPI B (Sigma-Aldrich, stock 
made in ethanol)). After incubation at 25 °C for 2 min, reactions 
were transferred to 10 °C for 5 min before the addition of 30 jjd 
of 0.6 m chymotrypsin (Sigma-Aldrich). After 5 min at 10 °C, 
the reaction was initialized with the substrate succinyl-Ala-Ala- 
Pro-Phe-j?-nitroanilide (Suc-AAPF-j?NA) at a final concentra­
tion of 78 (jlm (Bachem AG, Bubendorf, Switzerland; stock 
made in trifluoroethanol in the presence of 0.45 m LiCl (Sigma-
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TABLE 2
Conotoxins used in this study
The letter O in the peptide sequence represents hydroxyproline, and Z stands for 
pyroglutamic acid. #, denotes a C-terminal amidation; bold letters are conserved 
cysteines.
Species Toxin Sequence Disulfide scaffold
Conus geographus GIIIA RDCCTOOKKCKDROCKOQRCCA' M-conotoxin
Conus striatus SIIIA ZNCCNGGCSSKWCRDHARCC* rl--1 1cc—c-c-cc i-- -*
Conus magus MVIIC
CKGKGAPCRKTMYDCCSGSCGRRGKC* u>-conotoxin
MVIIC 07P CKGKGAOCRKTMYDCCSGSCGRRGKC* ri-1 1C~C-^C~C-C
Aldrich)). The cis-trans isomerization was measured by follow­
ing the absorbance at 390 nM in a Lambda 2 spectrophotometer 
(PerkinElmer Life Sciences). The mean and standard errors 
were calculated from three independent experiments.
Peptide Synthesis and Folding—Three conotoxins, /a-GIHA, 
/a-SIIIA, and w-MVIIC, derived from two distinct toxin gene 
families were selected for oxidative folding studies (Table 2). 
For MVIIC two analogues were synthesized, containing either a 
proline (jMVIIC) or a hydroxyproline (MVIIC OP7) in position 
7. All peptides were produced as described previously (47). 
Briefly, peptides were synthesized on a solid support by an auto­
mated peptide synthesizer using Fmoc (A/-(9-fluorenyl)me- 
thoxycarbonyl) protected amino acids, HBTU (0 -(benzotria- 
zol-l-yl)-l,l,3,3-tetramethyluronium hexafluorophosphate), 
and diisopropylethylamine (48). Peptides were cleaved from the 
resin by treatment with reagent K (trifluoroacetic acid/thioani- 
sole/ethanedithiol/water/phenol (90/5/5/2.5/7.5 by volume)) 
for 4-4.5 h. The peptides were subsequently filtered, precipi­
tated, and washed with cold methyl £er£-butyl ether. Linear pep­
tides were purified by reversed-phase HPLC on a semiprepara­
tive C18 column (Vydac, 5 /Am particle size, 10 X  250 mm; 
Grace, Deerfield, IL) using a linear gradient from 5 to 40% 
buffer B (90% acetonitrile, 0.1% trifluoroacetic acid) over 20 
min. Absorbance was monitored at 220 nm. Concentrations of 
SIIIA and MVIIC were determined spectrophotometrically 
using the molar absorption coefficient of the peptides at 280 
nm. The concentration of GIIIA was determined by HPLC. 
Oxidative folding reactions were carried out in 0.1 m Tris-HCl, 
pH 7.5, 1 mM EDTA, 0.1 mM reduced glutathione (GSH), and 
0.1 mM oxidized glutathione (GSSG) in the presence and 
absence of PPIase. Folding was initiated by adding the linear 
peptide at a final concentration of 20 /am. Aliquots were taken at 
various time points, and reactions were quenched by acidifica­
tion with formic acid at a final concentration of 8%. Folding 
reactions were analyzed by reversed-phase HPLC on a C18 col­
umn (Vydac, 5 /Am particle size, 4.6 X  250 mm; Grace) under 
the conditions described above. Native peptides were distin­
guished from linear peptides and other forms on the basis of 
characteristic HPLC elution profiles (18,47), mass spectromet- 
ric analyses of manually collected reversed-phase fractions 
(MALDI-TOF mass spectrometer, Ultraflex II in positive 
reflector mode, Bruker Daltonics, Bremen, Germany), and for 
the GIIIA experiments coelution with chemically synthesized 
biologically active GIIIA (18) (supplemental Figs. 1 and 2).
FIGURE 1. Proteomic identification of C o n u s PPIases. A  two-dimensional 
gel electrophoresis image of proteins extracted from the venom gland of 
C. novaehollandiae showing proteins subsequently identified as PDI, PPI A, 
and PPI B. 200 fig  of total protein was loaded onto nonlinear pH 3-11 IEF 
strips and separated on 8-16% Tris-HCl SDS-PAGE. Gel spots were excised, 
reduced, and alkylated, and trypsin was digested and analyzed by ESI-ion trap 
LC/MS/MS. Mass spectrometry results were searched against the UniProt pro­
tein data base using Mascot software. B, protein sequences of Conus PPI A (I), 
A (II), and B obtained by cDNA sequencing. Peptide matches generated by the 
data base search of the trypsin-digested gel spots are highlighted in gray 
(Mowse score >  54). Unique peptide matches are depicted in bold. The per­
centage of sequence coverage is shown.
RESULTS
Identification o f Conus PPI Isoforms Using a Combination o f  
Two-dimensional Gel Electrophoresis and cDNA Sequencing— 
Two-dimensional gel electrophoresis on venom gland proteins 
led to the identification of at least three different isoforms of 
PPIase excised from two distinct gel spots (Fig. LA). Data base 
searches revealed sequence similarities to cyclophilin A from a 
number of different species including the German cockroach 
(GenBankiM accession number CAA60869) and the medicinal 
leech (GenBankiM accession number AAB01531) and to cyclo­
philin B from the channel catfish (GenBankiM accession num­
ber ABC75555) and the yellow fever mosquito (GenBankiM 
accession number ABF18081). A number of unique peptides 
derived from two proteins were identified for one gel spot indi­
cating co-migration of two cyclophilin A isoforms, whereas the 
other gel spot contained one protein similar to cyclophilin B 
only. Using this unique sequence information, conventional 
RT-PCR, and RACE-PCR, a total of four PPIase isoforms were 
sequenced eventually (Fig. 2). Two cDNA transcripts showed 
high sequence similarities to cyclophilin A (PPI A) from a range 
of different organisms such as the Japanese scallop Chlamys 
farreri (identity, 81%; GenBankiM accession number 
AAR11779.1) and are hereafter referred to as Conus PPI A (I) 
and Conus PPI A (II). The A isoform of PPIase is located in the 
cytosol (49). The two transcripts have open reading frames of 
495 bases encoding proteins with a predicted molecular mass of
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17,523 and 17,542 Da. A third isoform with sequence identities 
of 73% to PPI B from Xenopus laevis (GenBank' M accession 
number AAH54168) and 7296 to PPI B from Homo sapiens 
(GenBank1 M accession number NP J )00933) has an open read­
ing frame of 621 bases encoding a protein with a predicted 
molecular mass of 22,614 Da. An N-terminal cleavage site 
between alanine 18 and aspartate 19 would release a mature 
peptide with an expected molecular mass of 20,821 Da as pre­
dicted by SignalP software (version 3.0). The presence of an 
N-terminal signal peptide and its homology to other B isoforms 
known to be located in the ER (Fig. 3) (49) strongly suggest that 
the mature protein resides in the ER. Thus, this isoform is here­
after referred to as Conus PPI B. The fourth cDNA transcript 
shares homology with peptidylprolyl isomerase-like 1 protein 
from a variety of organisms such as the copepod Caligus roger- 
cresseyi (similarity, 7896; GenBank'M accession number 
ACOH158) and M us musculus (similarity,749-6; GenBank'M 
accession number BAE33862). The molecular mass of the pre­
dicted protein is 18,560 Da encoded by an open reading frame 
of 507 bases. This isoform was designated Conus PPI C. Protein 
sequence alignment by means of local pairwise alignment (43) 
reveals high conservation of the key residues involved in sub­
strate binding between the four isoforms (Fig. 2) (50, 51), the 
only exception being the presence of serine 103 in PPI B and C 
instead of the conserved alanine 103 present in both PPI A 
isoforms. Re-evaluation of the two-dimensional gel electro­
phoresis data using the protein sequences predicted from the 
cDNA transcripts shows unique peptide matches and good 
sequence coverage for the two A isoforms, (I) and (II), co-mi- 
grating in one gel spot and PPI B (Fig. IS). Two-dimensional gel 
electrophoresis further confirmed the presence of two isoforms 
of Conus PDI with high sequence similarities to PDI from 
Conus marmoreus (13) (GenBank'M accession number 
ABF48564).
Reverse Transcription-PCR o f  Folding Enzymes across Differ­
ent Tissue Types— Conotoxins are synthesized in the epithelial 
cells of the long, tubular venom gland. In contrast, the venom 
bulb, a muscular organ located at the distal end of the venom 
gland, has been suggested to be involved in venom transloca­
tion rather than venom synthesis (52), whereas the muscle is 
simply involved in the locomotion of the snail. To assess the 
potential role of Conus PPIases in the folding of conotoxins, 
differential expression of the newly identified isoforms was 
determined for these three tissue types using RT-PCR. 
Although PPI A and PPI C were ubiquitously expressed across 
the tissue types tested, the ER-resident isoform B exhibited high 
mRNA expression in the venom gland alongside high expres­
sion levels of conotoxins for this organ (Fig. 4).
Expression Purification and Characterization o f  Conus PPI­
ase Isoforms— On the basis of its potential role in conotoxin 
folding, the putative mature ER-resident isoform PPI B was 
expressed in E, coli. The two cytosolic “A” isoforms also identi­
fied using both two-dimensional 
electrophoresis and cDNA se­
quencing were expressed for com­
parative studies. Purification of the 
soluble His-tagged fusion proteins 
using immobilized metal affinity 
and size exclusion chromatography 
yielded recombinant proteins of 
high purity (Fig. 5). The identities of 
all recombinant proteins were con­
firmed by nucleotide sequencing 
and LC/MS/MS analyses of the in­
gel-digested SDS-polyacrylamide 
gel bands (data not shown). To 
ensure the functionality of the 
recombinant PPI proteins, their 
prolyl cis-trans isomerase activity 
was tested using a modification of 
the coupled chymotrypsin assay
PPI A (I) M---------------------------------------------- ANPQVFFDIEIGGKPVGRIVMELRADWPKTAENFRALgjTGEK-
PPI A (II) M---------------------------------------------- ANPQVFFDITIGGQPAGRIVMELRADWPKTAENFRALgTGEK-
PPIB MLASGAVLILLVHAFALADDKPKGPKVTDKVYFDIEIGGMKAGRIIIGLFGKTVPKTAENFKQLAIGEKE
PPI C MAAITTQTRM----------------------------- QPPNITVETTMGA---------FVLEMYWKHAPTTiRNFVEL|--RR-
PPI A (I) GFGFKGSSFHRVIPGFMCQGGDFTRHNGTGGKSIYGNKFEDE-NFKLKHTGAGILSMANAGPNTNGSQFF
PPI A (II) GFGYKGSSFHRVIPGFXCQGGDFTNHNGTGGKSIYGNKFEDE-NFKLKHTEPGILSMANAGPNTNGSQFF
PPI B QLTYKGSKFHRVIKDFMIQGGDFTRGDGTGGRSIYGEKFPDE-NFKLKHYGAGWLSMANSGKDTNGSQFF
PPI C GY-YNGVKFHRIIQDFMIQGGDPT-GTGRGGSSIYGKNFNDEISEDLKHTGAGILSMANSGPDTNGSQFF
PPI A (I) LCTAKTQWLDGKHWFGNWDGMDWKAIELVGS DS-GTTSKKWIADtjGQL----------------------------
PPI A (II) LCTVKTTWLDGKHWFGSWEGMDWKAMEKLGSQS-GATSLKWIAD^GQL----------------------------
PPI B ITTKKTSWLDGRHWFGKILEGMDWRKIEGSKTDARDKPEKDWIADGGALEVTESFSVEKRDATE
PPI C ITLAPTQWLDGKHTIFGRVSSGMTVIQRMGLAETDSNDRPLDDVKIV------------------------KSYPTLT
FIGURE 2. Comparative alignment of PPIases identified in the venom gland of C. novaehollandiae (Gen­
B a n k ™  accession numbers: PPI A (I), GU046310; PPI A (II), GU046311; PPI B, GU046312; PPI C, 
GU046313). Alignment was performed using MAFFTE-INS-i by means of local pairwise alignment information 
(43). Side chains forming the binding cleft a re shown in bold (51). Cysteine residues are shaded. The predicted 
signal sequence of PPI B is underlined (SignalP). Dashes denote gaps. Amino acid conservations a re denoted by 
asterisks, whereas colons and periods represent a high and low degree of similarity, respectively.
FIGURE 3. Comparative alignment of the ER-resident B isoform of PPIases. Alignment was performed using MAFFT E-INS-i by means of local pairwise 
alignment information (43). Identical amino acids are outlined in black. Dashes denote gaps. Amino acid conservations are denoted by asterisks, whereas colons 
and periods represent a high and low degree of similarity, respectively.

















PPIase-assisted Folding o f Conotoxins
FIGURE 4. Differential expression of C o n u s PPIases and a-conotoxins across three different tissue types: the venom gland, the venom bulb, and the 
muscle tissue. A, RT-PCR showing high mRN A expression levels of the ER-resident folding enzyme PPI Bin the venom gland when compared with the bulb and 
muscle tissue. PPI A and PPI Care constitutively expressed across the different tissue types. Ferritin was used as a reference gene. nRT, no reverse transcriptase 
control; NTC, no template control. 8, schematic of cone snail and venom apparatus depicting orientation of histological section and histology showing the 
tissue used for RT-PCR, a 7-/xm section (scale bar: 500 ptm) stained with Mallory's trichrome stain.
FIGURE S. Expressed and purified PPIases cloned from the venom gland of 
C. n o v a e h o l l a n d i a e . C-terminal His-tagged fusion proteins were expressed in
E. coli (Rosetta strain) and purified using immobilized metal affinity chromatog­
raphy (IMAC) on the Profinia purification system (Bio-Rad) followed by size exclu­
sion chromatography (Superdex 200, GE Healthcare). 1 /xg of protein was loaded 
per lane. Ladder, unstained protein ladder (Invitrogen).
(46). All three enzymes exhibited peptidylprolyl isomerase 
activity that was reduced by preincubation of the reaction with 
the PPI inhibitor cyclosporine (Fig. 6). Interestingly, the two A 
isoforms were more active in catalyzing the prolyl cis-trans 
isomerization of the tetrapeptide Suc-Ala-Ala-Pro-Phe-pNA, 
and higher concentrations of PPI B (300 versus 30 nM for PPI A 
(I) and (II)) had to be used to obtain similar prolyl cis-trans 
conversion rates.
FIGURE 6. Peptidylprolyl cis-trans isomerase activity of C o n u s PPIase iso­
forms. Enzyme activity was tested using the coupled chymotrypsin assay 
with 30 nM PPI A (I) and (II) and 300 nM PPI B in the presence and absence of the 
PPIase inhibitor cyclosporine. Reactions containing chymotrypsin only 
served as base-line controls. Means ± S.E. were calculated from three inde­
pendent experiments.
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FIGURE 7. HPLC analysis of the oxidative folding of conotoxin ju,-GIIIA 
carried out in the presence of 0.1 m M  GSH and 0.1 m M  GSSG with and 
without Conus PPI B. Folding reactions were quenched at 0 (linear), 160, and 
1280 min (native) and analyzed by reversed-phase HPLC (C18 column, Vydac- 
Grace). Asterisks denote the folded species containing the native disulfide 
connectivity as determined by its characteristic elution profile (18) and coe­
lution studies with biologically active GIIIA (supplemental Fig. 1).
Conotoxin Folding Studies—To investigate the role of Conus 
PPIases in the folding of Pro- and Hyp-containing conotoxins, 
three conotoxins, namely /a-GIIIA, /a-SIIIA, and <w-MVIIC, 
were assayed. All three peptides had been studied previously in 
detail with respect to their oxidative folding properties (18, 53). 
GIIIA is 22 amino acids in length with a C-terminal amidation 
and six cysteines forming three disulfide bonds. The mature 
peptide contains three Hyp residues at position 6, 7, and 17 
(Table 2). NMR studies on GIIIA and its paralogue, GIIIB, 
strongly suggest a trans configuration of Hyp6 and Hyp1' , 
whereas Hyp' adopts a cis conformation (54, 55). The other 
/A-conotoxin tested, SIIIA, is 20 amino acids in length and is 
C-terminally amidated with the first amino acid being a pyro- 
glutamic acid. SIIIA shares its characteristic disulfide pattern 
with GIIIA but does not contain proline nor hydroxyproline 
residues. The <w-conotoxin jMVIIC is 26 amino acids in length, 
C-terminally amidated, and contains six cysteine residues 
forming three disulfide bonds (Table 2). MVIIC, which con­
tains one proline residue in position 7, is likely to adopt both cis 
and trans conformations (18). However, as the peptide 
sequence was originally deduced from cDNA sequence infor­
mation, hydroxylation of this proline residue may occur in vivo. 
Thus, both the proline (MVIIC)- and hydroxyproline (MVIIC 
7PO)-containing peptides were synthesized and tested.
All reversed-phase elution profiles of oxidative folding reac­
tions concurred with those reported previously (Fig. 7) (18,47). 
The molecular masses of the collected peaks agreed with the 
calculated masses as determined by MALDI-TOF mass spec­
trom etric analysis. Oxidative folding of /a-GIIIA was carried 
out in 0.1 m Tris-HCl, pH 7.5,1 mM EDTA, 0.1 mM GSH, and 0.1 
mM GSSG at room temperature. Under these conditions steady 
state accumulation of the native peptide occurred after approx­
imately 20 h (Fig. 8/1) with a half-time of 583 min (471-766 
min) (Fig. 8D  and Table 3). As the PPIase concentration in the 
ER was not known, enzymersubstrate ratios concurrent with 
previous studies were used (40, 56). In the presence of 0.5 /am 
Conus PPI B folding was accelerated —6-fold with a half-time of
100 min (77-141 min) (Fig. 8Dand Table 3). PPI B did not affect 
the final folding yields of the native species (51-52%, Table 3). 
The disappearance of the linear form was accelerated 3.8-fold 
(Fig. 8, B and D). Both the initial appearance and the subsequent 
disappearance of other folding intermediates occurred faster in 
the presence of PPI B (Fig. 8C). Mass spectrometric analysis of 
the other minor refolded species revealed partial oxidation of 
cysteine residues, glutathione adducts, and proline cis-trans 
isomers (supplemental Fig. 2). Enzyme activity was abolished 
when PPIase was heat-treated for 20 min at 95 °C prior to doing 
the folding assays (data not shown). Enzyme-assisted folding of 
GIIIA followed in a concentration-dependent manner (Fig. 9). 
At a concentration of 25 riM, PPI B showed little improvement 
in folding kinetics; however, when the enzyme concentration 
was increased to 2.5 /am, an exponential accumulation of the 
native peptide was observed (R-value, 0.97; half-time, 61 min 
(50 -78 min) (Fig. 9A)). In contrast, PPI B did not accelerate the 
oxidative folding of SIIIA, MVIIC, and MVIIC P70 under var­
ious conditions tested (data not shown). To examine the poten­
tial differences between PPI B and the two cytosolic isoforms 
PPI A (I) and (II), oxidative folding of GIIIA was carried out in 
the presence of 2.5 /am PPI A (I) and (II), respectively. Interest­
ingly, both PPI A isoforms were less capable of accelerating the 
folding of GIIIA than PPI B (Fig. 10/1) with half-times for the 
appearance of the native peptide of220 min (156 -375 min) for PPI 
A (I) and 244 min (173-414 min) for PPI A (II) at final concentra­
tions of 2.5 /am enzyme (Fig. 10S and Table 3). Because of the 
nature of the folding assay, constraints with enzyme and substrate 
concentrations did not allow for the formal measurement of 
kinetic parameters such as Km and £cat values.
DISCUSSION
Combining proteomics with targeted cDNA sequencing 
proved to be a highly successful technique for the discovery of 
novel proteins in the venom gland of Conus. Sequence informa­
tion obtained by two-dimensional gel electrophoresis and 
nucleotide sequencing was used for the functional character­
ization of a group of molecular chaperones, the peptidylprolyl 
cis-trans isomerases. This study describes for the first time the 
presence of multiple PPIase isoforms in the venom gland of 
Conus and evaluates PPIase-assisted oxidative folding of cono­
toxins in vitro. Further investigations using this integrated 
approach of proteomic and molecular analyses will facilitate the 
identification and characterization of additional venom gland 
proteins and provide insight into the generation of chemical 
diversity in Conus.
Despite their complex three-dimensional structure, which 
often comprises multiple disulfide bonds and posttranslational 
modifications (overview in Refs. 4 and 57), little is known about 
in vivo folding events in the ER of Conus. To date, the only 
ER-resident enzymes identified in Conus are 7-carboxylase (58) 
and PDI (14, 15). PDI was shown to be one of the major soluble 
proteins in the venom gland of Conus textile (14) and Conus 
amadis (15), and oxidative folding studies show PDI-assisted 
folding of a number of conotoxins in vitro including /a-GIIIA 
(13, 47, 59). Two-dimensional gel electrophoresis analysis of 
the venom gland proteome confirmed high abundances of this 
enzyme in the venom gland of C. novaehollandiae (Fig. 1/1). As
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FIGURE 8. Folding kinetics of f£-GIIIA in the presence of 0.1 m M  GSH and 0.1 m M  GSSG with and without 
Conus PPI B. The relative abundance of the correctly folded (4), linear (8), and other folding species (C) was 
determined by HPLC as shown in Fig. 7. The plotted values are averages from three independent experiments. 
Nonlinear regression analysis was performed on plotted data, and half-times for the appearance and disap­
pearance were calculated for the native and linear forms, respectively (0).
shown for a number of proline-con­
taining proteins including ribonu- 
clease Tl, PPIase can improve the 
efficiency of PDI-mediated folding 
by providing partially folded protein 
chains with the correct proline iso­
mers (56). As folding intermediates 
are highly susceptible to degrada­
tion, accelerating the time needed 
from translation at the ribosome 
to generation of the protein in its 
final three-dimensional structure 
is energetically advantageous. The 
epithelial cells of the venom gland 
are highly specialized in peptide 
biosynthesis and secretion and 
energetically rely upon fast turnover 
rates.
Here, we have shown that Conus 
PPIases can significantly accelerate 
the formation of the native disulfide 
bonds for conotoxin /x-GIIIA, 
revealing that peptidylprolyl isom­
erization is a rate-limiting step in 
the oxidative folding of this cono­
toxin. The native peptide contain­
ing three disulfide bonds appeared 
~6 times faster in the presence of 
PPI B. Concomitantly, both the dis­
appearance of the linear form and 
the appearance and subsequent dis­
appearance of other folding species 
were accelerated when Conus PPI B 
was added to the folding reaction 
(Figs. 7 and 8). Changes in the fold­
ing kinetics followed in a concen­
tration-dependent manner with 
10-fold higher folding rates for 
GIIIA in the presence of 2.5 /am PPI 
B (Fig. 9). No difference in GIIIA 
folding was observed when heat- 
treated enzyme was added to the 
folding reaction (data not shown).
As all three prolines in /x-GIIIA 
are posttranslationally modified, we 
have further demonstrated that a 
4-hydroxyproline-containing cono­
toxin can be recognized by Conus 
PPIase, a finding reported previ­
ously for collagen (19,20). Hydroxy- 
lation of prolines is believed to be 
catalyzed by prolyl 4-hydroxylase. 
Interestingly, PDI is a subunit of 
prolyl 4-hydroxylase, and hydroxy- 
lation, formation of the native disul­
fide bonds, and cis-trans isomeriza­
tion of Hyp residues may occur 
concurrently. Recently a complex
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TABLE 3
Half-times for the appearance of ft-GIIIA containing native disulfide 
connectivity in the presence of Conus PPIases
Half-times were calculatd by non-linear regression. The numbers in parentheses 
represent the upper and lower 95% confidence interval.
Enzyme Half-time for appearance of native form
/in min
No enzyme 583(471-766)
PPI B, 0.025 275 (190-495)
PPI B, 0.1 181 (140-257)
PPI B, 0.5 100 (77-141)
PPI B, 2.5 61 (50-78)
PPI A (I), 2.5 220 (156-375)
PPI A (II), 2.5 244(173-414)
FIGURE 9. Folding kinetics of ^ -GIIIA in the presence of 0.1 m M  GSH and 
0.1 itim GSSG and different concentrations of Conus PPI B. A, the plotted 
values are averages from three independent experiments. Nonlinear regres­
sion analysis was performed on the plotted data, and half-times were calcu­
lated for the appearance of the peptide containing the native disulfide con­
nectivity (Bj.
comprising prolyl 3-hydroxylase-l, cartilage-associated pro­
tein (CRTAP), and cyclophilin B was identified in chick 
embryos and shown to act as a chaperone for collagen (60). 
Similar complexes might be present in the ER of Conus, and 
their discovery would contribute greatly to our knowledge of 
the biosynthesis of conotoxins and other disulfide-rich small 
peptides.
Mature GIIIA is 22 amino adds in length and contains three 
Hyp residues in position 6,7, and 17 (Table 2). NMR studies on 
GIIIA and its paralogue, GIIIB, strongly suggest a trans config­
uration of Hyp6 and Hyp17, whereas Hyp7 adopts a cis confor­
mation (54, 55). Under unstrained conditions, e.g. during trans-
FIGURE 10. Folding kinetics of fi-GIIIA in the presence of 0.1 m M  GSH and 
0.1 m M  GSSG and different isoforms of Conus PPIase. A, the effects of PPI A 
(I), PPI A (II), and PPI B on the oxidative folding of GIIIA were tested at a final 
concentration of 2.5 fiM enzyme. The plotted values are averages from three 
independent experiments. Nonlinear regression analysis was performed on 
the plotted data, and half-times were calculated for the appearance of the 
peptide containing the native disulfide connectivity (8).
lation at the ribosomes, most prolyl peptide bonds adopt a trans 
configuration (61). Therefore, for proteins containing both cis 
and trans prolines, the folding kinetics are driven by the trans- 
to-cis isomerization, and the contribution of the trans prolines 
can be neglected (39). As a consequence, cis-Pro7 is likely to 
dominate the folding kinetics of GIIIA. However, slow interme­
diate trans-to-cis isomerizations of Pro6 and Pro17 during for­
mation and/or reshuffling of disulfide bonds cannot be ruled 
out.
The presence of PPIase did not affect the folding kinetics of 
w-MVIIC and ju,-SIIIA under the various conditions tested. The 
inability of Conus PPIs to accelerate the folding of SIIIA is not 
surprising, as this peptide does not contain Pro or Hyp residues. 
MVIIC is a w-conotoxin with one Pro/Hyp residue likely to be 
present as mixed cis/trans isomers (18). Isomerization of the 
Pro/Hyp residue might not represent a rate-limiting step in the 
oxidative folding of jMVIIC. Alternatively, jMVIIC may not rep­
resent a suitable substrate for Conus PPIases. Both jMVIIC and 
GIIIA comprise three disulfide bonds, are similar in length, and 
have comparable charge states at pH 7.5 (pH +4.2 for GIIIA 
and +5.2 for jMVIIC). Studies addressing the substrate speci­
ficities of the PPIases of the cyclophilin family reveal the broad 
specificities of these enzymes (62,63). However, short tetrapep- 
tides were the only substrates tested in these studies (62, 63), 
and differences in substrate recognition and affinity between 
GIIIA and MVIIC cannot be excluded, especially considering

















PPIase-assisted Folding o f Conotoxins
the significant differences in their disulfide patterns and pri­
mary amino acid sequences (see Table 2). Future studies using a 
variety of conotoxins with sequence similarities to GIIIA and 
MVIIC will shed light on substrate specificities of Conus 
PPIases.
RT-PCR on the venom gland, bulb, and muscle tissue 
revealed high expression levels of the ER-resident isoform PPI B 
in the venom gland of C. novaehollandiae (Fig. 4). As opposed 
to the bulb and the muscle, the venom gland is highly special­
ized for toxin biosynthesis, and up-regulation of PPI B strongly 
indicates a predominant role of this isoform in protein/peptide 
folding as reported for the human ER-resident PPIases CypB 
and FKBP-13 (36, 37). Furthermore, we have shown that Conus 
PPI B is approximately five times more efficient in accelerating 
the folding of GIIIA than the two cytosolic isoforms, PPI A (I) 
and A (II) (Fig. 10), but is less active in catalyzing the isomer­
ization of the tetrapeptide Suc-AAPF-pNA (Fig. 6). These find­
ings indicate a potential and specialized role of PPI B in the in 
vivo folding of conotoxins. Differences in catalytic efficacy 
between the A and B isoform have previously been reported for 
the trematode Schistosoma mansoni (64) and recently for 
human cyclophilins (65). Human CypA and CypB both recog­
nize several proline residues on domain 2 of hepatitis C virus 
NS5A protein but with different catalytic efficiencies (65). For 
S. mansoni recombinant CypB was two to three times more 
active than CypA when tested against Suc-AAPF-pNA. As for 
Conus PPI A (I + II) and B, the amino acid residues important 
for substrate binding were highly conserved between the two 
isoforms with the only difference being the presence of serine 
103 in PPIase B instead of the conserved alanine 103 for the A 
isoform. Although the authors (64) suggested that this amino 
acid replacement might cause the differences in substrate bind­
ing affinities, later studies demonstrated that the cytosolic A 
isoform can adopt two redox states, significantly impairing the 
enzyme activity (66). Under oxidizing conditions S. mansoni 
PPI A exhibits one disulfide bond, leading to a significant 
change in the binding pocket of the enzyme, thus impeding 
activity. A similar observation was made for cyclophilin 
CYP20-3 isolated from the chloroplasts of Arabidopsis thali- 
ana (67, 68). CYP20-3, believed to be regulated by thioredoxin 
(68), comprises two disulfide bonds in its oxidized, inactive 
state (67). Conus PPI A (I) and (II) contain four cysteines in their 
primary amino acid sequence (Fig. 2). Formation of disulfide 
bonds between these cysteine residues may occur especially 
under the oxidizing conditions necessary for the conotoxin 
folding experiments. Only one cysteine remains conserved in 
the ER-resident Conus PPIase (Fig. 2), implying a potential 
adaptation of this isoform to the oxidizing conditions in the 
ER. Structural studies on the different PPIase isoforms under 
oxidizing and reducing conditions and in complex with Suc- 
AAPF-pNA, ju,-GIIIA, and other potential conotoxin sub­
strates will provide insight into the existence of redox states, 
differences in enzyme activities, and substrate recognition 
properties.
In summary, this study has identified the first members of the 
PPIase family in marine cone snails, animals that specialize in 
the biosynthesis of cysteine-rich peptides. We have demon­
strated that a venom gland ER-resident isoform preferentially
APRIL 23, 2010-VOLUME 285'NUMBER 17
catalyzes the refolding of a conotoxin that contains three 
hydroxyprolines. These observations suggest that this isoform 
may have co-evolved with the toxin arsenal to efficiently pro­
duce the diverse venom repertoire of the Conus species. It is 
anticipated that Conus PPIases may act in concert with other 
foldases, such as PDI and prolyl 4-hydroxylase, to facilitate 
conotoxin biosynthesis. The characterization of these enzymes 
provides insights into the fundamental process of the folding of 
toxins and related polypeptides as well as having potential 
industrial application to the large scale production of toxins as 
therapeutics.
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